ACE2 and COVID-19: The precise method by which COVID-19 lymphopenia develops is unknown, however it could be connected to lymphocyte expression of the main SARS-CoV-2 entry receptor, ACE2, and subsequent lymphoid death as a result of infection [23, 24].